Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | -612 | -20,950 |
| Depreciation Amortization | 292 | 470 |
| Accounts receivable | 546 | N/A |
| Accounts payable and accrued liabilities | -822 | N/A |
| Other Working Capital | 56,940 | 30,140 |
| Other Operating Activity | 414 | 340 |
| Operating Cash Flow | $56,758 | $10,000 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -232 | -910 |
| Investing Cash Flow | $-232 | $-910 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 21,923 | 19,080 |
| Financing Cash Flow | $21,923 | $19,080 |
| Beginning Cash Position | 33,341 | 5,170 |
| End Cash Position | 111,790 | 33,340 |
| Net Cash Flow | $78,449 | $28,160 |
| Free Cash Flow | ||
| Operating Cash Flow | 56,758 | 10,000 |
| Capital Expenditure | -232 | N/A |
| Free Cash Flow | 56,526 | 10,000 |